Skip to main content
Log in

Lack of association between plasminogen activator inhibitor type-1 (PAI-1) gene 4G/5G polymorphism and osteoarthritis

  • Short Communication
  • Published:
Rheumatology International Aims and scope Submit manuscript

Abstract

This study was conducted in Turkish osteoarthritis patients to determine the frequency of 4G/5G polymorphism genotypes of plasminogen activator inhibitor type-1 gene and to examine the role of this polymorphism in osteoarthritis development. Genomic DNA obtained from 200 persons (140 patients with osteoarthritis and 60 healthy controls) was used in the study. DNA was amplified by polymerase chain reaction using 4G allele- and 5G allele-specific primers. Polymerase chain reaction products were assessed with CCD camera by being exposed to 2% agarose gel electrophoresis. No statistically significant difference between the groups with respect to genotype distribution was found (P > 0.05) in the study. The 4G allele frequency was indicated as 44% and 5G allele was as 56% in patients, whereas this was 45–55% in the control group. This study has established that 4G/5G polymorphism genotypes of plasminogen activator inhibitor type-1 gene do not play a role in the development of osteoarthritis in the Turkish population.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Ashraf S, Walsh DA (2008) Angiogenesis in osteoarthritis. Curr Opin Rheumatol 20:573–580

    Article  PubMed  Google Scholar 

  2. Burnett BP, Levy R, Cole BJ (2006) Metabolic mechanisms in the pathogenesis of osteoarthritis. J Knee Surg 19(3):191–197

    PubMed  Google Scholar 

  3. Michael JWP, Schlüter-Brust KU, Eysel P (2010) The epidemiology, etiology, diagnosis, and treatment of osteoarthritis of the knee. Dtsch Arztebl Int 107(9):152–162

    PubMed  Google Scholar 

  4. Akyüz G, Bulak E (2007) Osteoartritte ağrı nedenleri. Ağrı 19(1):31–35

    PubMed  Google Scholar 

  5. Altman RD (2010) Early management of osteoarthritis. Am J Manag Care 16:41–47

    Google Scholar 

  6. Wu Q, Zhu M, Rosier RN, Zuscik MJ, O’Keefe RJ, Chen D (2010) Beta-catenin, cartilage, and osteoarthritis. Ann N Y Acad Sci 1192(1):344–350

    Article  PubMed  CAS  Google Scholar 

  7. Ronday HK, Smits HH, Muijen GNPV, Pruszczynski MSM, Dolhain RJEM, Langelaan EJV, Breedveld FC, Verheijen JH (1996) Difference in expression of the plasminogen activation system in synovial tissue of patients with rheumatoid arthritis and osteoarthritis. Br J Rheumatol 35:416–423

    Article  PubMed  CAS  Google Scholar 

  8. Cerinic MM, Generini S, Partsch G, Pignone A, Dini G, Konttinen YT, Rosso MD (1998) Synoviocytes from osteoarthritis and rheumatoid arthritis produce plasminogen activators and plasminogen activator inhibitor-1 and display u-PA receptors on their surface. Life Sci 63(6):441–453

    Article  PubMed  CAS  Google Scholar 

  9. Belcher C, Fawthrop F, Bunning R, Doherty M (1996) Plasminogen activators and their inhibitors in synovial fluids from normal, osteoarthritis, and rheumatoid arthritis knees. Ann Rheum Dis 55:230–236

    Article  PubMed  CAS  Google Scholar 

  10. Gunes HV, Cosan DT, Ata N, Birdane A, Ustuner MC, Dikmen M, Bayram B, Degirmenci I (2010) Plasminogen activator inhibitor type-1 gene 4G/5G polymorphism is associated with hypertensive patients in Turkish population. Genet Test Mol Biomarkers 14(3):303–305

    Article  PubMed  CAS  Google Scholar 

  11. Kellgren JK, Lawrence JS (1957) Radiological assessment of osteoarthritis. Ann Rheum Dis 16:494–501

    Article  PubMed  CAS  Google Scholar 

  12. Lequesne M, Mry C, Samson M, Gerard P (1987) Indexes of severity for osteoarthritis of the hip and knee. Validation-value in comparison with aother assessment tests. Scand J Rheumatol 65:85–89

    Article  CAS  Google Scholar 

  13. Bayram B, Sayın E, Güneş HV, Değirmenci İ, Türkoğlu Z, Doğaner F, Turgut Coşan D (2010) DD genotype of ACE gene I/D polymorphism is associated in a turkish study population with osteoarthritis. Mol Biol Rep. doi:10.1007/s11033-010-0284-y

  14. Torres-Carrillo NM, Torres-Carrillo N, Mercado MV, Delgado-Rizo V, Oregon-Romero E, Parra-Rojas I, Munoz-V JF (2008) The -844 G/A PAI-1 polymorphism is associated with mRNA expression in rheumatoid arthritis. Rheumatol Int 28:355–360

    Article  PubMed  CAS  Google Scholar 

  15. Cosan D, Kurt E, Kurt H, Degirmenci I, Kucukarabaci B, Metintas M, Urhan M, Gunes HV, Colak E (2009) Plasminogen activator inhibitor type-1 (PAI-1) gene 4G/5G polymorphism in patients with asthma in Turkish adult patients with asthma. Genet Test Mol Biomark 13(4):543–546

    Article  CAS  Google Scholar 

  16. Kucukarabaci B, Gunes HV, Ozdemir G, Cosan D, Ozbabalik D, Dikmen M, Degirmenci I (2008) Investigation of association between plasminogen activator inhibitor type-1 (PAI-1) Gene 4G/5G Polymorphism frequency and plasma PAI-1 enzyme activity in patients with acute stroke. Genet Test 12(3):443–451

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

We thank the Department of Physiology Laboratories of Medical Faculty of Eskişehir Osmangazi University.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Banu Bayram.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bayram, B., Sayin, E., Erkasap, N. et al. Lack of association between plasminogen activator inhibitor type-1 (PAI-1) gene 4G/5G polymorphism and osteoarthritis. Rheumatol Int 32, 259–262 (2012). https://doi.org/10.1007/s00296-010-1737-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00296-010-1737-2

Keywords

Navigation